Early results from a trial of a new kidney disease medication show it significantly reduces levels of a urine marker of kidney damage. The experimental drug — called BI 690517 for now — cut levels of the liver protein albumin in the urine in half for patients with chronic kidney disease. Albumin levels in urine… read on > read on >


















